NewEdge Advisors’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$460K Sell
4,330
-58
-1% -$6.59K ﹤0.01% 2055
2025
Q4
$467K Buy
4,388
+4,300
+4,886% +$434K ﹤0.01% 2020
2025
Q3
$8.25K Hold
88
﹤0.01% 3387
2025
Q2
$7.63K Hold
88
﹤0.01% 3287
2025
Q1
$6.79K Sell
88
-18,185
-100% -$1.67M ﹤0.01% 3213
2024
Q4
$1.77M Buy
18,273
+1,159
+7% +$117K 0.01% 876
2024
Q3
$1.62M Buy
17,114
+533
+3% +$46.5K 0.01% 889
2024
Q2
$1.38M Buy
+16,581
New +$1.38M 0.01% 918
2024
Q1
Sell
-24
Closed -$1.99K 3810
2023
Q4
$1.99K Sell
24
-3,041
-99% -$223K ﹤0.01% 3339
2023
Q3
$220K Buy
3,065
+597
+24% +$45.3K ﹤0.01% 1592
2023
Q2
$187K Buy
+2,468
New +$166K ﹤0.01% 1656
2023
Q1
Sell
-52
Closed -$2.83K 3417
2022
Q4
$2.83K Buy
+52
New +$3.09K ﹤0.01% 2743

Other funds holding ACA

NewEdge Advisors's ACA Position: Q1 2026 in Review

NewEdge Advisors reduced its Arcosa (ACA) stake by 1.3% in Q1 2026, selling an estimated $6.59K and leaving 4,330 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #2055.

NewEdge Advisors first reported a position in ACA in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.77M in Q4 2024. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • NewEdge Advisors held 4,330 shares of Arcosa worth $460K as of Q1 2026.
  • NewEdge Advisors sold 58 Arcosa shares in Q1 2026, an estimated $6.59K.
  • Arcosa made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2055 holding.
  • NewEdge Advisors first reported a position in Arcosa in Q4 2022 and has held it in 12 quarters since.
  • NewEdge Advisors's Arcosa position peaked at $1.77M in Q4 2024.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.